ResearcherCarol Davila University of Medicine and PharmacyActive in the last 2 years
Cătălin Cârstoiu
Matched on OpenAlex author ID A5083692269. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2026: 2 papers
Papers 2
- Distinct Inflammatory and Dissemination Signatures Defined by Macrophage Migration Inhibitory Factor (MIF), Interleukin-8 (IL-8/CXCL8), and Stem Cell Factor (S… Last author DOI 10.3390/diagnostics16091373↗
- Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) in Pancreatic Adenocarcinoma. Last author DOI 10.3390/ijms27031562↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Augustin Cătălin Dima · 2 shared papers, 2026 · strength 0.54
- Paper Distinct Inflammatory and Dissemination Signatures Defined by Macrophage Migration Inhibitory Factor (MIF), Interleukin… DOI 10.3390/diagnostics16091373↗
- Paper Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) … DOI 10.3390/ijms27031562↗
- Mariana Jinga · 2 shared papers, 2026 · strength 0.54
- Paper Distinct Inflammatory and Dissemination Signatures Defined by Macrophage Migration Inhibitory Factor (MIF), Interleukin… DOI 10.3390/diagnostics16091373↗
- Paper Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) … DOI 10.3390/ijms27031562↗
- Daniel Vasile Balaban · 2 shared papers, 2026 · strength 0.54
- Paper Distinct Inflammatory and Dissemination Signatures Defined by Macrophage Migration Inhibitory Factor (MIF), Interleukin… DOI 10.3390/diagnostics16091373↗
- Paper Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) … DOI 10.3390/ijms27031562↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.